Respiratory syncytial virus and influenza activity are on the rise in parts of the country, particularly among young children, according to the CDC's latest respiratory virus updates. Overall, the ...

Doctors recommend that adults aged 75 or older should look into a single dose of the RSV vaccine, while adults 60 or older with an underlying health condition should ask about their RSV vaccination ...

Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and ...

Ardent Solutions, in partnership with the Allegany County Department of Health, is hosting a series of vaccination clinics in November as part of the U.S. Department of Health ...

RSV vaccination for infants and mothers should be administered either in the hospital or directly from a primary health-care ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Moderna (MRNA) announced Health Canada has approved mRESVIA for active immunization for the prevention of lower respiratory tract disease caused by respiratory syncytial virus in adults 60 years of ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses.

Health professionals recommend vaccines before traveling to celebrate the holidays with family. If you missed the early fall ...

FDA Approvals and Expansions In May, the FDA approved the mRNA-1345 RSV vaccine (mResvia) from Moderna for people ages 60 and ...